Kiss Industries

Kiss Therapeutics is a biotechnology company focused on developing novel therapies for reproductive health and endocrine disorders by targeting the kisspeptin pathway. The company's research centers on kisspeptin analogs, which act as potent stimulators of the hypothalamic-pituitary-gonadal axis, essential for regulating human fertility. Their lead programs aim to provide more physiological treatments for conditions such as infertility, polycystic ovary syndrome (PCOS), and various forms of hypogonadism. By leveraging deep expertise in kisspeptin biology, Kiss Therapeutics seeks to offer alternatives to traditional hormone replacement therapies and assisted reproductive technologies.